Group 2:immunotherapy

Effects of intestinal microbiome diversity on the efficacy and survival of chemotherapy combined with immunotherapy and immunotherapy in advanced non-small cell lung cancer

Feasibility study of circulating tumor cells (CTC) and their HIF-1a mRNA expression levels in evaluating the efficacy of downstaging and conversion therapy and monitoring of postoperative recurrence risk in middle-advanced primary liver cance